Wave Life Sciences (WVE) announced the appointment of Christopher Wright, MD, PhD, as Chief Medical Officer, CMO. Dr. Wright will join Wave’s executive team and lead global development, including medical, clinical and regulatory functions, to bring the company’s RNA medicines to countless individuals who urgently need them.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Wave Life Sciences: Strategic Advancements and Promising Developments Justify Buy Rating
- Innovative Therapeutics and Promising Clinical Data Drive Buy Rating for Wave Life Sciences
- Wave Life Sciences Reports Q1 2025 Financials and Progress
- Wave Life Sciences: Strong Growth Potential with Upcoming Catalysts and Solid Financial Position
- Wave Life Sciences Reports Q1 2025 Financial Results